Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How You Will Achieve More With Intellia:
The Director, Forecasting Lead plays a crucial role in driving Intellia’s success by executing forecasting initiatives to guide proper commercial performance expectations setting.
This role will partner closely with commercial operations, market access, supply, finance, and marketing teams to assess the commercial opportunity for each pipeline asset. It involves refining the level of confidence of key assumptions and translating long-term forecasts into short-term launch forecasts for our late-stage gene editing pipeline assets.
This role will report to the VP of Commercial Operations.
Responsibilities:
-
Develop, implement, and facilitate Intellia’s commercial forecasting process, including setting up internal timelines, defining ways of working within the cross-functional team, and facilitating internal readouts with program teams and the leadership team.
-
Identify areas for improvement in existing forecast models, including evolving long-term forecasts into launch forecasts.
-
Collaborate with internal and external stakeholders to map insight gaps and inform the confidence level of assumptions.
-
Work closely with various internal stakeholders to incorporate the latest thinking related to launch timelines, LOEs, and the impact of new competitive entries.
-
Create short-term monthly forecasts quarterly, combining data trends and assumptions to set commercial goals and support strategic and tactical business decisions.
-
Develop innovative approaches to appropriately forecast one time therapy annual long-range planning process.
-
Develop business cases to support the internal assessment of strategic initiatives, such as quantifying the impact of indication expansion and new clinical studies.
-
Collaborate with sales operations to translate national goals into regional and territory sales targets.
-
Work closely with the supply chain team to establish Intellia’s SOP processes for manufacturing and inventory management.
-
Build an excel-based market model to forecast pipeline uptake and project market evolution of its competitors.
-
Prepared both formal and ad hoc analyses on market trends, competitors, product performance, market opportunities, and risks.
-
Model impact of contracting changes to support Market Access scenario planning.
-
Develop tools to monitor brand performance and executive reports to the leadership team
About You:
-
Results-driven self-starter with a strong sense of accountability, performance orientation, and the ability to collaborate effectively across functional teams
-
Track record of successfully supporting senior leadership with U.S. market forecasting and analytics
-
Strong strategic agility with the ability to analyze complex business issues, adapt to evolving market and competitive dynamics, and establish proper objectives.
-
Strong presentation skills with ability to distil and summarize information for presentation to Senior Leadership.
-
Ability to operate in a fast-paced, entrepreneurial, and collaborative environment; strong interpersonal skills and ability to work positively with others.
-
Exceptional skills in proactivity, planning, and project/meeting management.
-
Organized and logical, with a high degree of flexibility to change direction when needed.
-
BA/BS in a quantitative field required.
-
10 years of experience in the pharmaceutical industry with strong focus in the US market.
-
At least 5 years of experience in forecasting, including rare diseases required.
-
Experience in cell/gene therapy, rare immunology desired.
#LI-SV1
#LI-Hybrid
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
What We Do
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.
Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology’s attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic.
View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/